HomeGLAB • CNSX
add
Gemina Laboratories Ltd
Previous close
$0.68
Year range
$0.28 - $0.90
Market cap
50.71M CAD
Avg Volume
23.94K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 918.99K | -41.77% |
Net income | -962.31K | 39.02% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -913.67K | 41.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 206.84K | 79.78% |
Total assets | 1.50M | -18.95% |
Total liabilities | 4.15M | 137.12% |
Total equity | -2.66M | — |
Shares outstanding | 74.57M | — |
Price to book | -17.00 | — |
Return on assets | -156.48% | — |
Return on capital | 189.13% | — |
Cash Flow
Net change in cash
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Net income | -962.31K | 39.02% |
Cash from operations | -284.56K | 68.92% |
Cash from investing | — | — |
Cash from financing | 489.74K | 2,523.37% |
Net change in cash | 205.18K | 121.66% |
Free cash flow | 21.76K | — |
About
Founded
2017
Headquarters
Website
Employees
6
